OSAIC HOLDINGS, INC. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$746,690
+25.6%
19,547
+18.8%
0.00%0.0%
Q2 2023$594,734
+25.8%
16,457
+32.2%
0.00%0.0%
Q1 2023$472,897
-74.5%
12,449
-61.8%
0.00%
-75.0%
Q4 2022$1,854,211
+56.7%
32,616
+9.0%
0.00%
+33.3%
Q3 2022$1,183,000
-33.3%
29,924
-25.7%
0.00%
-25.0%
Q2 2022$1,774,000
+216.8%
40,300
+185.3%
0.00%
+300.0%
Q1 2022$560,000
-10.5%
14,125
-9.4%
0.00%0.0%
Q4 2021$626,000
-41.4%
15,589
-40.6%
0.00%
-50.0%
Q3 2021$1,068,000
+71.4%
26,263
+92.2%
0.00%
+100.0%
Q2 2021$623,000
+12.5%
13,662
+3.5%
0.00%0.0%
Q1 2021$554,000
-78.4%
13,202
-78.0%
0.00%
-85.7%
Q4 2020$2,569,000
+801.4%
60,125
+459.1%
0.01%
+600.0%
Q3 2020$285,000
-15.2%
10,754
-14.4%
0.00%0.0%
Q2 2020$336,000
+127.0%
12,557
+53.2%
0.00%0.0%
Q1 2020$148,0008,1990.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders